Search
Oct 25
Kojin Therapeutics Chairman & CEO Harvey Berger shares an update on the company's progress and talks about the funding environment for earlier stage companies in biotech
Biotech industry veteran Harvery Berger talks about his company's job at hand to translate the science of ferroptosis into therapies....
Jan 10
Biotech veteran Harvey Berger on why he joined Kojin Therapeutics
Harvey Berger describes the science of ferroptosis and his experience working with Kojin's scientific founder Stuart Schreiber.